Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cancer therapy-induced cardiotoxicity].

P Frères1, A Poncin1, M Moonen2

  • 1Service d'Oncologie Médicale, CHU de Liège, Belgique.

Revue Medicale De Liege
|April 7, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac angiosarcoma.

Acta cardiologica·2025
Same author

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.

Breast cancer research : BCR·2023
Same author

Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease.

Acta cardiologica·2023
Same author

HIDEA syndrome: A new case report highlighting similarities with ROHHAD syndrome.

Frontiers in genetics·2023
Same author

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.

ESMO open·2023
Same author

[A new approach in coronary interventional cardiology: the distal radial approach].

Revue medicale de Liege·2022

Cancer treatments can harm the heart, leading to cancer-therapy-induced cardiotoxicity. This summary covers its causes, monitoring, and management to improve patient care.

Area of Science:

  • Oncology
  • Cardiology
  • Internal Medicine

Background:

  • Rising cancer incidence necessitates aggressive treatments.
  • Cytotoxic therapies frequently cause severe side effects.
  • Cancer-therapy-induced cardiotoxicity is a life-threatening complication impacting treatment continuity.

Purpose of the Study:

  • To review the mechanisms of cancer-therapy-induced cardiotoxicity.
  • To outline current monitoring strategies for at-risk patients.
  • To describe the multidisciplinary management approach for this condition.

Main Methods:

  • Literature review on cancer-therapy-induced cardiotoxicity.
  • Synthesis of information on pathophysiological mechanisms.
  • Compilation of data on diagnostic and management guidelines.
Keywords:
CancerCardiotoxicityChemotherapyTherapiesTrastuzumab

Related Experiment Videos

Main Results:

  • Cardiotoxicity results from various direct and indirect effects of cancer therapies.
  • Early detection through monitoring is crucial for intervention.
  • A coordinated, multidisciplinary approach is essential for optimal patient outcomes.

Conclusions:

  • Understanding cardiotoxicity mechanisms aids prevention and treatment.
  • Regular monitoring allows for timely detection and management.
  • Multidisciplinary care improves the prognosis for patients experiencing cardiotoxicity.